nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrabenazine—Epigastric pain—Hydrochlorothiazide—nephrolithiasis	0.072	0.113	CcSEcCtD
Tetrabenazine—Memory impairment—Hydrochlorothiazide—nephrolithiasis	0.0443	0.0697	CcSEcCtD
Tetrabenazine—CBR1—NRF2 pathway—SLC2A9—nephrolithiasis	0.0355	0.0976	CbGpPWpGaD
Tetrabenazine—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.0315	0.0495	CcSEcCtD
Tetrabenazine—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.0292	0.0459	CcSEcCtD
Tetrabenazine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.0247	0.0678	CbGpPWpGaD
Tetrabenazine—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.0238	0.0373	CcSEcCtD
Tetrabenazine—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.0231	0.0363	CcSEcCtD
Tetrabenazine—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.0231	0.0363	CcSEcCtD
Tetrabenazine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.0229	0.063	CbGpPWpGaD
Tetrabenazine—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.0228	0.0359	CcSEcCtD
Tetrabenazine—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.0218	0.0343	CcSEcCtD
Tetrabenazine—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.0204	0.0321	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.0203	0.0319	CcSEcCtD
Tetrabenazine—Sweating—Hydrochlorothiazide—nephrolithiasis	0.0187	0.0293	CcSEcCtD
Tetrabenazine—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0178	0.028	CcSEcCtD
Tetrabenazine—DRD2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0168	0.0461	CbGpPWpGaD
Tetrabenazine—SLC18A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.0162	0.0444	CbGpPWpGaD
Tetrabenazine—Tension—Hydrochlorothiazide—nephrolithiasis	0.0149	0.0235	CcSEcCtD
Tetrabenazine—SLC18A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.0148	0.0406	CbGpPWpGaD
Tetrabenazine—SLC18A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.0148	0.0406	CbGpPWpGaD
Tetrabenazine—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.0148	0.0232	CcSEcCtD
Tetrabenazine—Tremor—Hydrochlorothiazide—nephrolithiasis	0.0143	0.0224	CcSEcCtD
Tetrabenazine—DRD2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0141	0.0387	CbGpPWpGaD
Tetrabenazine—Agitation—Hydrochlorothiazide—nephrolithiasis	0.014	0.022	CcSEcCtD
Tetrabenazine—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.0136	0.0214	CcSEcCtD
Tetrabenazine—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.0129	0.0203	CcSEcCtD
Tetrabenazine—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.0127	0.0199	CcSEcCtD
Tetrabenazine—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.0125	0.0197	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.012	0.0189	CcSEcCtD
Tetrabenazine—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0182	CcSEcCtD
Tetrabenazine—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0177	CcSEcCtD
Tetrabenazine—SLC18A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.0112	0.0308	CbGpPWpGaD
Tetrabenazine—SLC18A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.0112	0.0308	CbGpPWpGaD
Tetrabenazine—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.0111	0.0174	CcSEcCtD
Tetrabenazine—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.011	0.0174	CcSEcCtD
Tetrabenazine—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.0108	0.017	CcSEcCtD
Tetrabenazine—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0168	CcSEcCtD
Tetrabenazine—Constipation—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0167	CcSEcCtD
Tetrabenazine—SLC18A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.0104	0.0286	CbGpPWpGaD
Tetrabenazine—SLC18A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.0104	0.0286	CbGpPWpGaD
Tetrabenazine—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0161	CcSEcCtD
Tetrabenazine—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00982	0.0154	CcSEcCtD
Tetrabenazine—SLC18A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00928	0.0255	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00922	0.0253	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00922	0.0253	CbGpPWpGaD
Tetrabenazine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00891	0.014	CcSEcCtD
Tetrabenazine—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.0085	0.0134	CcSEcCtD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00821	0.0226	CbGpPWpGaD
Tetrabenazine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00821	0.0129	CcSEcCtD
Tetrabenazine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.0079	0.0124	CcSEcCtD
Tetrabenazine—Headache—Hydrochlorothiazide—nephrolithiasis	0.00778	0.0122	CcSEcCtD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00751	0.0207	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00751	0.0207	CbGpPWpGaD
Tetrabenazine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00738	0.0116	CcSEcCtD
Tetrabenazine—DRD2—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00713	0.0196	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—GRHPR—nephrolithiasis	0.00703	0.0193	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—AGXT—nephrolithiasis	0.00626	0.0172	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00569	0.0157	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00569	0.0157	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—APRT—nephrolithiasis	0.00532	0.0146	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—SLC26A1—nephrolithiasis	0.00532	0.0146	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00529	0.0146	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00529	0.0146	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00472	0.013	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00472	0.013	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.00405	0.0111	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—AQP1—nephrolithiasis	0.00379	0.0104	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00377	0.0104	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—CHRM3—nephrolithiasis	0.00343	0.00943	CbGpPWpGaD
Tetrabenazine—DRD2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00323	0.00889	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00277	0.00762	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—RGS14—nephrolithiasis	0.00244	0.00671	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—RGS14—nephrolithiasis	0.00222	0.00609	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—CHRM3—nephrolithiasis	0.00211	0.0058	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—PTH—nephrolithiasis	0.00193	0.0053	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—DGKH—nephrolithiasis	0.00165	0.00453	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ADCY10—nephrolithiasis	0.00154	0.00423	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—DGKH—nephrolithiasis	0.0015	0.00412	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—RGS14—nephrolithiasis	0.00131	0.0036	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00119	0.00328	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PTH—nephrolithiasis	0.00109	0.003	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CHRM3—nephrolithiasis	0.00108	0.00298	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PTH—nephrolithiasis	0.00099	0.00272	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.000913	0.00251	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000884	0.00243	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—DGKH—nephrolithiasis	0.000884	0.00243	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.000814	0.00224	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—APRT—nephrolithiasis	0.000692	0.0019	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	0.000692	0.0019	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CHRM3—nephrolithiasis	0.000639	0.00176	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PTH—nephrolithiasis	0.000585	0.00161	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—AQP1—nephrolithiasis	0.000493	0.00136	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CHRM3—nephrolithiasis	0.000446	0.00123	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SPP1—nephrolithiasis	0.000294	0.000807	CbGpPWpGaD
